ACT-AD Executive Director Cynthia Bens Testifies on MDUFA and PDUFA Reauthorization
Earlier this month, ACT-AD Executive Director Cynthia Bens testified before the U.S. Senate Committee on Health, Education, Labor, and Pensions about the reauthorization of the Medical Device User Fee Act (MDUFA) and Prescription Drug User Fee Act (PDUFA). Bens’ testimony at the hearing can be found here.
Missed ACT-AD’s Webinar on Symptomatic Relief for Alzheimer’s Disease? Watch It Here!
Last month, ACT-AD hosted a webinar on symptomatic relief for Alzheimer’s disease. The one-hour webinar featured expert perspectives on the burden of Alzheimer’s disease, highlighted advances in neurobiology, and provided updates on recent clinical trial development activities to improve the treatment of Alzheimer’s disease symptoms. Find an on-demand replay of the webinar here.
Save the Date for ACT-AD’s Tenth Annual FDA/AD Allies Meeting, November 16
Mark your calendars! ACT-AD’s Tenth Annual FDA/AD Allies Meeting is set for Thursday, November 16, 2017, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland 20852). The meeting will begin at 9:30 a.m. and end by 4:00 p.m. More information will be available on the ACT-AD website.
FDA Approves Sale of At-Home Genetic Testing Kits for 10 Diseases, Including Alzheimer’s
For the first time ever, the U.S. Food and Drug Administration recently allowed the sale of consumer tests for genetic health risks. The 23andMe Personal Genome Service Genetic Health Risk (GHR) tests provide information on genetic risks but do not determine consumers’ overall risk for developing a disease. The company says the testing kits can detect the risk of late-onset Alzheimer’s disease, Parkinson’s disease, and others. Learn how genetics plays a role in developing Alzheimer’s in this resource and learn more about GHR tests here.
Researchers Say They Have Identified Link Between Neurodegenerative Disease and Birth Defects
University of Maryland researchers say they have found a link between diabetic pregnant women who give birth to children with neurological birth defects and neurological diseases, such as Alzheimer’s disease and Parkinson’s disease. The research team used animal models in their study, finding the embryos of diabetic models contained misfolded clumps of proteins associated with neurodegenerative diseases. Learn more about the study here.
Risk Factors for Vascular Disease in Middle Age May Be Linked to AD in Later Years
Researchers say multiple risk factors for vascular disease in midlife leads to an increased risk of developing Alzheimer’s disease. The study found that people with two or more risk factors for vascular disease had higher levels of beta-amyloid in their brains. To learn more about the study, go here.
AFA Concepts in Care Educational Conference for Caregivers, May 5, 2017
The Alzheimer’s Foundation of America (AFA) will host an educational conference for family and professional caregivers, individuals with dementia, and the community in New York City on May 5, 2017. The conference will feature expert information on access to care, perceptions of aging, and clinical trials and research. To learn more about the conference, go here.
Save the Date for NIA’s Inclusion Across the Lifespan Workshop, June 1-2, 2017
The National Institute on Aging (NIA) will convene an expert workshop on appropriate inclusion of pediatric and older populations in research studies involving human subjects. The workshop will address barriers and opportunities for these populations to get involved in clinical studies. For more details about the workshop, go here.
ADDF’s Conference on Alzheimer’s Drug Discovery, September 11-12, 2017
The Alzheimer’s Drug Discovery Foundation will hold its 18th Annual International Conference on Alzheimer’s Drug Discovery in Jersey City, New Jersey. The two-day event will gather top researchers, who are developing innovative treatments for Alzheimer’s disease and related dementias. Scholarships are available for graduate students and postdoctoral fellows to attend the conference at no cost. More information about the scholarship can be found here. General details about the conference are available here.